Home News & Events Events Workshops Workshops Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 19 May 2026 - 20 May 2026 Time 08:00 - 18:00 Location Online/Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 21 May 2026 Time 09:00 - 17:00 Location Online/Webex Timezone America/New York Workshop New and Advanced Features of NONMEM 7.6 Workshop Date 1 June 2026 Time 09:00 - 17:00 Location Dubrovnik, Croatia Timezone Europe/Bratislava In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Event Webinars Event Industry Events What’s happening in ICON ICON Plc Join ICON at World Vaccine Congress 2026 as we share our latest insights in HIV vaccine and therapeutic development. With 30+ HIV studies, 13,800+ participants, and 20+ years of operational experience across 27 African a... 27 Mar View post View webpage ICON Plc Latest issue out now. Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our fr... 27 Mar View post View webpage ICON Plc China’s biotech sector continues its strong growth trajectory, creating new opportunities for global innovation. In this latest BioXconomy analysis, Yao Zhong, Vice President and General Manager for ICON China Mainland a... 27 Mar 3 View post View webpage ICON Plc Bioanalytical strategy is central to successful biosimilar development. Our latest spotlight explores how scientific advancements are helping teams strengthen comparability, improve accuracy and accelerate development ti... 27 Mar 1 View post View webpage ICON Plc Advances in biosimilar development demand bioanalytical strategies that are robust, adaptive and scientifically rigorous. Discover 6 elements of a successful strategy to support biosimilar development and how innovators ... 27 Mar View post View webpage ICON Plc As ADCs expand into new indications—including rare cancers and potential autoimmune applications—regulatory pathways continue to adapt. ICON’s regulatory expert, Eilidh Mayer, examines how accelerated approvals, orphan ... 26 Mar View post View webpage ICON Plc With increasing approvals across Asia and beyond, ADCs remain one of the most dynamic areas in oncology innovation. ICON’s new publication highlights the critical elements of regulatory engagement, dose optimisation and ... 26 Mar 2 View post View webpage ICON Plc ICON and Advarra have entered a new partnership to introduce a ‘research-ready’, connected site network model that will transform how clinical trials are operationalised globally. The model will integrate ICON’s clinica... 25 Mar View post View webpage ICON Plc Meet with ICON experts at the GLP-1-Based Therapeutics Summit to gain valuable insights on obesity clinical development and learn about our ready-to-deploy infrastructure designed to accelerate obesity and comorbidity pr... 25 Mar View post View webpage ICON Plc How to navigate EU MAA Regulations and Registration For Chinese pharma and biotech companies looking to expand into the European Union’s market of over 450 million people, the first step is to understand the significant... 25 Mar View post View webpage ICON Plc ICON is heading to #AMCP2026 from 13–16 April, and our team is looking forward to engaging with leaders across the managed care and market access community. Visit us at booth \#1412 to learn how ICON’s evidence generatio... 25 Mar View post View webpage ICON Plc Earlier this month, our teams across ICON came together around the world to celebrate International Women’s Day. From team celebrations and office events to shared moments of reflection, this year’s theme, Give to Gain,... 25 Mar View post
